Fundz

Equilibre Bio Pharmaceuticals Corp reported raising $6 Million in an initial SEC Form D filing, from an offering of $6 Million

PRIVATEDec 01, 2022

Amount Raised

$6 Million

$6 Million sold, per SEC Form D (first sale Nov 16, 2022)

Round Type

Venture

New YorkHealthcare

Quick answer

Equilibre BioPharmaceuticals Corp raised $6 Million in a funding round, dated November 16, 2022. Equilibre BioPharmaceuticals Corp is based in New York, New York, United States.

How much did Equilibre BioPharmaceuticals Corp raise?
Equilibre BioPharmaceuticals Corp raised $6 Million in a funding round on November 16, 2022.
What does Equilibre BioPharmaceuticals Corp do?
We recognize our success is a product of the numerous contributions of our executive officers, scientific, financial, legal, technical personnel and consultants.
Where is Equilibre BioPharmaceuticals Corp based and how big is it?
Equilibre BioPharmaceuticals Corp is based in New York, New York, United States.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Equilibre BioPharmaceuticals Corp that raised within 45 days of this round, from Fundz verified event records.

  • Koha Health raised $1M (Seed) on December 31, 2022.
  • PlantFuel Life Inc raised $198K (Seed) on December 30, 2022.
  • ByHeart raised $30M on December 30, 2022.
  • Palarum LLC raised $3.7M (Seed) on December 30, 2022.
  • Live Circle raised $85K (Pre-Seed) on December 30, 2022.
  • Modify Health raised $10M on December 30, 2022.

Who to call at Equilibre BioPharmaceuticals Corp, and when

A new round usually means Equilibre BioPharmaceuticals Corp is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Equilibre BioPharmaceuticals Corp raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Equilibre BioPharmaceuticals Corp, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Equilibre BioPharmaceuticals Corp. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Equilibre BioPharmaceuticals Corp

Location

New York, New York, United States

About

We recognize our success is a product of the numerous contributions of our executive officers, scientific, financial, legal, technical personnel and consultants. As we continue to implement our growth strategy, as well as acquire and develop technologies, we will continue to rely on their expertise and dedication.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Equilibre BioPharmaceuticals Corp raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Equilibre BioPharmaceuticals Corp's next move

See what Strategic adds

Equilibre BioPharmaceuticals Corp raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.